← All trials
NCT04706598
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 9, 2021
- Primary completion
- Sep 30, 2022
- Completion date
- Jun 30, 2023
- First posted
- Jan 13, 2021
- Last posted
- Oct 12, 2021
- Enrollment
- 56
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Fudan UniversityLead sponsor
- Jiao Tong UniversityStudy director
- Jiao Tong UniversityStudy director
- Shanghai Shen Kang HospitalCollaborator
- Tongji UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.